Second Primary Malignancies in Cancer Survivors
| Autor: | Angela F. Bazzell, Danielle M. Fournier |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Advanced and Specialized Nursing
Oncology medicine.medical_specialty education.field_of_study Cancer survivor business.industry Population Late effect Cancer medicine.disease Malignancy 03 medical and health sciences 0302 clinical medicine Breast cancer 030220 oncology & carcinogenesis Internal medicine Cancer screening medicine 030212 general & internal medicine medicine.symptom business education Thyroid cancer |
| Zdroj: | The Journal for Nurse Practitioners. 14:238-244 |
| ISSN: | 1555-4155 |
| DOI: | 10.1016/j.nurpra.2017.09.026 |
| Popis: | Advances in early detection and treatment of cancer have resulted in a growing population of cancer survivors across the United States. Cancer survivors may be at increased risk for the development of a second primary malignancy as a result of environmental factors, genetic predisposition, or as a late effect of the cancer treatment they received. This review examines the risk for second primary malignancy and necessary screening in the six cancers with the highest 5-year survival rates, including: breast cancer, Hodgkin's lymphoma, melanoma, prostate, testicular, and thyroid cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect